抗PD1/PDL1抗体的临床试验
总计231个结果
-
Merck Sharp & Dohme LLC招聘中非小细胞肺癌 | 实体瘤 | 程序性细胞死亡-1(PD1、PD-1) | 程序性细胞死亡 1 配体 1(PDL1, PD-L1) | 程序性细胞死亡 1 配体 2(PDL2、PD-L2)日本
-
University of ZurichIncyte Corporation尚未招聘出疹 | 抗 PD1 肿瘤治疗下出现苔藓样皮疹
-
Sun Yat-sen UniversitySecond Affiliated Hospital of Guangzhou Medical University完全的
-
Shanghai Zhongshan HospitalRenJi Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Public... 和其他合作者招聘中
-
Chinese PLA General Hospital招聘中
-
Second Affiliated Hospital, School of Medicine,...First People's Hospital of Hangzhou招聘中
-
Zhejiang Cancer Hospital主动,不招人
-
Second Affiliated Hospital of Guangzhou Medical...Guangdong Zhaotai InVivo Biomedicine Co. Ltd.招聘中
-
Targovax Oy完全的PD1 阻断后进展的晚期或不可切除的黑色素瘤美国, 挪威
-
Assistance Publique - Hôpitaux de ParisEtablissement Français du Sang (Nouvelle Aquitaine)招聘中
-
Università Politecnica delle Marche尚未招聘淋巴瘤 | 肺肿瘤 | 结核 | EGF-R阳性非小细胞肺癌 | 结节病 | 纵隔淋巴结肿大 | 肺门淋巴结肿大 | ROS1基因突变 | PDL1基因突变 | ALK易位意大利
-
Medical University of Graz终止
-
Chinese PLA General Hospital招聘中
-
Yale UniversityMerck Sharp & Dohme LLC招聘中黑色素瘤 | 肾细胞癌 | 转移性黑色素瘤 | 脑转移 | 派姆单抗 | 乐伐替尼 | PD1/PD-L1 经验丰富美国
-
Xencor, Inc.ICON plc完全的黑色素瘤 | 肾细胞癌 | 宫颈癌 | 鼻咽癌 | 小细胞肺癌 | 肝细胞癌 | 胸腺癌 | 胸腺瘤 | 非小细胞肺癌 | 间皮瘤 | 头颈部鳞状细胞癌 | 胆管癌 | 乳腺癌 | 输卵管癌 | 子宫内膜癌 | 尿路上皮癌 | 去势抵抗性前列腺癌 | 大肠癌 | 卵巢癌 | 神经内分泌癌 | 基底细胞癌 | 阴茎鳞状细胞癌 | 外阴癌 | 肛门鳞状细胞癌 | 胃或胃食管结合部腺癌 | 实体瘤已发表抗 PD1/PDL1 和/或抗 CTLA4 定向疗法具有抗肿瘤活性的证据 | 恶性附件肿瘤 | 非鳞状细胞唾液腺癌美国
-
West China HospitalFirst Affiliated Hospital of Chongqing Medical University; Sichuan Cancer Hospital and Research... 和其他合作者招聘中
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin尚未招聘
-
Shanghai International Medical Center未知
-
Zhejiang Cancer Hospital尚未招聘胃癌、HIPEC、抗 PD-1 抗体 Camrelizumab (SHR-1210)、化疗和手术中国
-
Mårten SegelmarkHansa Biopharma AB完全的
-
Staidson (Beijing) Biopharmaceuticals Co., Ltd完全的
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes... 和其他合作者撤销
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)撤销
-
Nantes University HospitalINSERM UMRS-1064完全的
-
Xiangya Hospital of Central South UniversityThe Third Xiangya Hospital of Central South University; Hunan Provincial People's Hospital; Central... 和其他合作者招聘中
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)终止
-
Chinese PLA General Hospital尚未招聘
-
Chinese SLE Treatment And Research GroupThe First Affiliated Hospital of Anhui Medical University; Shanghai Zhongshan Hospital; Second... 和其他合作者招聘中